TIM - Tbilisi Institute of Medicine LLC

Tbilisi 160

1 studies enrolling now · 3 studies all time

What they study most

Dermatitis, Atopic, Melanoma, Moderate to Severe Plaque Psoriasis, Non-small Cell Lung Cancer, Renal Cell Carcinoma

Studies at this site

• A Phase I Clinical Study to Evaluate the PK Profile, Efficacy, Safety and Immunogenicity of HLX17 vs. Keytruda® in Multiple Resected Solid Tumors — Recruiting now
• To Assess the Effect of SCD-044 Treatment on Moderate to Severe Plaque Psoriasis — Completed
• To Assess the Efficacy and Safety of SCD-044 in the Treatment of Moderate to Severe Atopic Dermatitis — Completed